Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease

Parkinson's disease (PD) is characterized by elevated expression of an abnormal metabolic brain network that is reduced by clinically effective treatment. We used fluorodeoxyglucose (FDG) positron emission tomography (PET) to determine the basis for motor improvement in 12 PD patients receiving...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Feigin, Andrew, Kaplitt, Michael G., Tang, Chengke, Lin, Tanya, Mattis, Paul, Dhawan, Vijay, During, Matthew J., Eidelberg, David
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: National Academy of Sciences 2007
Konular:
Biological Sciences
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2148328/
https://ncbi.nlm.nih.gov/pubmed/18042721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0706006104
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller